Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access colorectal cancer specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colorectal cancer treatment provided free
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events and change in disease activity when ABBV-400 is given in combination with Fluorouracil, Folinic Acid, and Bevacizumab to adult participants to treat unresctable metastatic colorectal cancer. ABBV-400 is an investigational drug being developed for the treatment of unresectable metastatic colorectal cancer. Fluorouracil, folinic acid, and bevacizuma
Sponsor: AbbVie
Check if you qualify for this colorectal cancer clinical trial in Phoenix, AZ
If you're searching for colorectal cancer treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.